Stockreport

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

NeuroMetrix, Inc.  (NURO) 
Last neurometrix, inc. earnings: 4/20 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.neurometrix.com/investor-relations
PDF WOBURN, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted the recent publication of a large study demonstrating that DPNCheck® combined [Read more]